Showing 1 - 16 results of 16 for search 'Ansari-Pour, N', query time: 0.06s
Refine Results
-
1
Why, when and how to adjust your p values? by Jafari, M, Ansari-Pour, N
Published 2019Journal article -
2
-
3
A logic-based dynamic modeling approach to explicate the evolution of the central dogma of molecular biology by Jafari, M, Ansari-Pour, N, Azimzadeh, S, Mirzaie, M
Published 2017Journal article -
4
Systems genetics of nonsyndromic orofacial clefting provides insights into its complex aetiology by Razaghi-Moghadam, Z, Namipashaki, A, Farahmand, S, Ansari-Pour, N
Published 2018Journal article -
5
Re-evaluating experimental validation in the Big Data era: a conceptual argument by Jafari, M, Guan, Y, Wedge, DC, Ansari-Pour, N
Published 2021Journal article -
6
-
7
Systems biomedicine of rabies delineates the affected signaling pathways by Azimzadeh Jamalkandi, S, Mozhgani, S, Gholami Pourbadie, H, Mirzaie, M, Noorbakhsh, F, Vaziri, B, Gholami, A, Ansari-Pour, N, Jafari, M
Published 2016Journal article -
8
Little genetic differentiation as assessed by uniparental markers in the presence of substantial language variation in peoples of the Cross River region of Nigeria. by Veeramah, K, Connell, B, Ansari Pour, N, Powell, A, Plaster, C, Zeitlyn, D, Mendell, N, Weale, M, Bradman, N, Thomas, MG
Published 2010Journal article -
9
Genetic legacy of state centralization in the Kuba Kingdom of the Democratic Republic of the Congo by Van Dorp, L, Lowes, S, Weigel, JL, Ansari-Pour, N, López, S, Mendoza-Revilla, J, Robinson, JA, Henrich, J, Thomas, MG, Nunn, N, Hellenthal, G
Published 2018Journal article -
10
-
11
Loss of COP9 signalosome gene-containing 2q region is associated with lenalidomide and pomalidomide resistance in myeloma patients by Gooding, S, Ansari-Pour, N, Kazeroun, MH, Karagoz, K, Salazar, MA, Fitzsimons, E, Estevez, MO, Towfic, F, Flynt, E, Pierceall, WE, Yong, K, Vyas, P, Thakurta, A
Published 2021Conference item -
12
Multiple cereblon genetic changes are associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma by Gooding, S, Ansari-Pour, N, Towfic, F, Ortiz Estévez, M, Chamberlain, PP, Tsai, K-T, Flynt, E, Hirst, M, Rozelle, D, Dhiman, P, Neri, P, Ramasamy, K, Bahlis, N, Vyas, P, Thakurta, A
Published 2020Journal article -
13
Loss Of COP9-signalosome genes Aa 2q37 is associated with IMiD agent resistance in multiple myeloma by Gooding, S, Ansari-Pour, N, Kazeroun, MH, Karagoz, K, Polonskaia, A, Angulo Salazar, M, Fitzsimons, E, Sirinukunwattana, K, Chavda, SJ, Ortiz Estevez, M, Towfic, F, Flynt, E, Pierceall, W, Royston, D, Yong, KL, Ramasamy, K, Vyas, P, Thakurta, A
Published 2022Journal article -
14
Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer. by Ruark, E, Snape, K, Humburg, P, Loveday, C, Bajrami, I, Brough, R, Rodrigues, D, Renwick, A, Seal, S, Ramsay, E, Duarte, S, Rivas, M, Warren-Perry, M, Zachariou, A, Campion-Flora, A, Hanks, S, Murray, A, Ansari Pour, N, Douglas, J, Gregory, L, Rimmer, A, Walker, N, Yang, T, Adlard, J, Barwell, J
Published 2013Journal article -
15
Multi-site clonality analysis uncovers pervasive heterogeneity across melanoma metastases by Rabbie, R, Ansari-Pour, N, Cast, O, Lau, D, Scott, F, Welsh, SJ, Parkinson, C, Khoja, L, Moore, L, Tullett, M, Wong, K, Ferreira, I, Gómez, JMM, Levesque, M, Gallagher, FA, Jiménez-Sánchez, A, Riva, L, Miller, ML, Allinson, K, Campbell, PJ, Corrie, P, Wedge, DC, Adams, DJ
Published 2020Journal article -
16
Whole-genome analysis of Nigerian patients with breast cancer reveals ethnic-driven somatic evolution and distinct genomic subtypes by Ansari-Pour, N, Zheng, Y, Yoshimatsu, TF, Sanni, A, Ajani, M, Reynier, J-B, Tapinos, A, Pitt, JJ, Dentro, S, Woodard, A, Rajagopal, PS, Fitzgerald, D, Gruber, AJ, Odetunde, A, Popoola, A, Falusi, AG, Babalola, CP, Ogundiran, T, Ibrahim, N, Barretina, J, Van Loo, P, Chen, M, White, KP, Ojengbede, O, Obafunwa, J, Huo, D, Wedge, DC, Olopade, OI
Published 2021Journal article